All articles by Pradeep Bairaboina
AbbVie to acquire Nimble Therapeutics in $200m deal
The deal will provide AbbVie access to Nimble’s proprietary peptide synthesis platform, which facilitates the discovery and optimisation of oral peptide therapeutics.
Catalent and Novo Holdings to finalise acquisition following regulatory clearance
The agreement, initially announced in February, involves Novo Holdings acquiring Catalent and Novo Nordisk purchasing three fill-finish manufacturing sites from Catalent for $11bn